Clearside Biomedical, Inc. - Common Stock (CLSD)
0.9300
-0.0100 (-1.06%)
Clearside Biomedical is a biopharmaceutical company focused on developing innovative therapies for eye diseases
The company specializes in the delivery of drugs to the back of the eye, utilizing its proprietary suprachoroidal injection platform to enhance treatment efficacy and minimize side effects. Clearside’s pipeline includes formulations targeting conditions such as wet age-related macular degeneration and other retinal disorders, with the aim of providing improved therapeutic options for patients suffering from these debilitating conditions. Through its advancements in ocular drug delivery, Clearside seeks to transform the treatment landscape for various eye diseases.
Frequently Asked Questions
Is Clearside Biomedical, Inc. - Common Stock publicly traded?
Yes, Clearside Biomedical, Inc. - Common Stock is publicly traded.
What exchange does Clearside Biomedical, Inc. - Common Stock trade on?
Clearside Biomedical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Clearside Biomedical, Inc. - Common Stock?
The ticker symbol for Clearside Biomedical, Inc. - Common Stock is CLSD on the Nasdaq Stock Market
What is the current price of Clearside Biomedical, Inc. - Common Stock?
The current price of Clearside Biomedical, Inc. - Common Stock is 0.9300
When was Clearside Biomedical, Inc. - Common Stock last traded?
The last trade of Clearside Biomedical, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Clearside Biomedical, Inc. - Common Stock?
The market capitalization of Clearside Biomedical, Inc. - Common Stock is 57.35M
How many shares of Clearside Biomedical, Inc. - Common Stock are outstanding?
Clearside Biomedical, Inc. - Common Stock has 61.67M shares outstanding.